Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma

被引：0
|
作者：
Merz, Maximilian [1 ]
Raab, Marc S. [1 ,2 ]
Goldschmidt, Hartmut [1 ,3 ]
Hillengass, Jens [1 ,4 ]
机构：
[1] Univ Heidelberg Hosp, Hematol Oncol & Rheumatol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Max Eder Grp Expt Therapies Hematol Malignancies, Heidelberg, Germany
[3] Natl Ctr Tumor Dis, Heidelberg, Germany
[4] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 2017年 / 143卷 / 12期
关键词：
Multiple myeloma; Autologous transplantation; Daratumumab; Elotuzumab; Ixazomib; Carfilzomib;
D O I：
10.1007/s00432-017-2463-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The 6th Heidelberg Myeloma Workshop was held on May 5th and 6th, 2017 in the lecture hall of the University Hospital Heidelberg. Main topics of the meeting were (1) biology and genomics of multiple myeloma, (2) diagnostics and prognostic factors, (3) role of immunotherapy in multiple myeloma, as well as (4) therapy of multiple myeloma-drugs and treatment strategies. The landscape for the treatment of newly diagnosed and relapsed disease has significantly changed since the last Heidelberg Myeloma Workshop in 2015. Updates on the current developments were presented at the meeting.
引用
收藏
页码：2521 / 2526
页数：6
相关论文
共 36 条
  • [1] Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
    Maximilian Merz
    Marc S. Raab
    Hartmut Goldschmidt
    Jens Hillengass
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2521 - 2526
  • [2] Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
    Merz, Maximilian
    Hillengass, Jens
    Goldschmidt, Hartmut
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 247 - 251
  • [3] Meeting report of the 4th Heidelberg Myeloma Workshop: Current status and developments in diagnosis and therapy of multiple myeloma
    Jens Hillengass
    Merz Maximilian
    Hartmut Goldschmidt
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1807 - 1811
  • [4] Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma
    Maximilian Merz
    Jens Hillengass
    Hartmut Goldschmidt
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 247 - 251
  • [5] Meeting report of the 4th Heidelberg Myeloma Workshop: Current status and developments in diagnosis and therapy of multiple myeloma
    Hillengass, Jens
    Maximilian, Merz
    Goldschmidt, Hartmut
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (11) : 1807 - 1811
  • [6] Meeting report of the third Heidelberg myeloma workshop: current status and developments in diagnosis and therapy of multiple myeloma
    Jens Hillengaß
    Kai Neben
    Hartmut Goldschmidt
    Journal of Cancer Research and Clinical Oncology, 2012, 138 (1) : 173 - 178
  • [7] Current status and developments in diagnosis and therapy of multiple myeloma
    Jens Hillengass
    Kai Neben
    Hartmut Goldschmidt
    Journal of Cancer Research and Clinical Oncology, 2010, 136 (1)
  • [8] Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow
    M. A. Baertsch
    R. Lutz
    M. S. Raab
    N. Weinhold
    H. Goldschmidt
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2445 - 2455
  • [9] Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow
    Baertsch, M. A.
    Lutz, R.
    Raab, M. S.
    Weinhold, N.
    Goldschmidt, H.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (10) : 2445 - 2455
  • [10] Therapy strategies for multiple myeloma: current status
    Gisslinger, H
    Kees, M
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (13-14) : 451 - 461
1234